Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934

In 2024, nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 trade exhibited strong growth, with global flows reaching $27,032,739,541 and a three-year compound annual growth rate of -2.5% (five-year: +10.7%). The all-time peak of $29,137,965,313 was recorded in 2021; the current level is 7% below that high-water mark.

Over the 30-year observation window (1995–2024), 76% of years recorded positive growth, indicating a predominantly expanding market. Trend momentum is decelerating (-7.0% acceleration).

The supply side is diversified (Herfindahl-Hirschman Index 0.112). The three largest exporters — Ireland ($6.2B), China ($4.2B), and Singapore ($2.8B) — collectively dominate supply flows. The leading exporter has grown at -1.4% over the last three years.

On the demand side, importer concentration is diversified (HHI 0.113). The three largest import markets are United States ($6.2B), Germany ($5.8B), and Spain ($1.5B). The largest importing market sources from 53 different supplying countries.

The dominant trade corridor is Ireland → Germany at $3.3B, representing 56.4% of the importer's total demand.

The volatility score for nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 is 6 out of 100, classified as low. Trade flows are relatively stable compared to other HS6 products, suggesting mature supply chains and predictable demand.

For market entrants, strong demand tailwinds create a favourable entry environment. The diversified supply landscape means many competitors but also multiple entry points and buyer relationships to target.

Data confidence is rated "High" based on reporting coverage and consistency across OECD member and partner countries.